BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8027239)

  • 1. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy.
    Sealey JE; Itskovitz-Eldor J; Rubattu S; James GD; August P; Thaler I; Levron J; Laragh JH
    J Clin Endocrinol Metab; 1994 Jul; 79(1):258-64. PubMed ID: 8027239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations.
    Itskovitz J; Sealey JE; Glorioso N; Rosenwaks Z
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7285-9. PubMed ID: 3118364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S; Kubota T; Aso T
    Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoradiometric assay for active renin and plasma prorenin during cycles stimulated by IVFET or GIFT].
    Guichard A; Mignot TM; Boyer P; Zorn JR; Cedard L
    Reprod Nutr Dev (1980); 1988; 28(6B):1731-40. PubMed ID: 3150115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators.
    Manau D; Balasch J; Arroyo V; Jiménez W; Fábregues F; Casamitjana R; Creus M; Vanrell JA
    J Clin Endocrinol Metab; 1998 May; 83(5):1489-93. PubMed ID: 9589644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles.
    Holst N; Jenssen TG; Burhol PG; Haug E; Forsdahl F
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1160-6. PubMed ID: 2498386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations.
    Kaider AS; Coulam CB
    Early Pregnancy (Cherry Hill); 2000 Jul; 4(3):191-9. PubMed ID: 11727011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
    Oelkers W; Berger V; Bolik A; Bähr V; Hazard B; Beier S; Elger W; Heithecker A
    J Clin Endocrinol Metab; 1991 Oct; 73(4):837-42. PubMed ID: 1890155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
    Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
    J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome.
    Navot D; Margalioth EJ; Laufer N; Birkenfeld A; Relou A; Rosler A; Schenker JG
    Fertil Steril; 1987 Jul; 48(1):57-61. PubMed ID: 2439386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The follicular phase stimulated by human pituitary gonadotropin and the luteal phase following in vitro fertilization.
    Friedrich W; Lisse K; Körner H; Wilken T
    Exp Clin Endocrinol; 1986 Jun; 87(1):1-7. PubMed ID: 3743641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between aldosterone and progesterone in the human menstrual cycle.
    Szmuilowicz ED; Adler GK; Williams JS; Green DE; Yao TM; Hopkins PN; Seely EW
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3981-7. PubMed ID: 16868049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.
    Moraloğlu Ö; Tonguc EA; Özel M; Özakşit G; Var T; Sarikaya E
    Arch Gynecol Obstet; 2012 Mar; 285(3):857-62. PubMed ID: 21938500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.
    Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.